AACC welcomes you. We prefer to discuss any question about your document by phone rather than email, Please call us at (202) 347-5800.
Arab drug regulators, such as Saudi Arabia’s SFDA, Egypt’s drug authority and the UAE’s health authorities, generally require a legalized Certificate of a Pharmaceutical Product (COPP) before they register a U.S. medicine. The COPP follows the WHO certification format and is issued by the FDA, so it is legalized as a federal document. The Arab American Chamber of Commerce handles the U.S. Department of State and embassy steps.
Issued by the FDA, legalized in Washington. A COPP never needs a notary or a Secretary of State. It goes straight to the U.S. Department of State. For Saudi Arabia, Morocco, Bahrain and Algeria that apostille is enough. Drug registrations in the other Arab countries also need the embassy.
A Certificate of a Pharmaceutical Product (also called a CPP) is issued under the WHO certification scheme for pharmaceuticals moving in international trade. The FDA issues it to confirm a drug’s U.S. marketing status and that the manufacturing site follows good manufacturing practice (GMP). Importing countries use it as the cornerstone of the drug registration file.
For drugs approved and marketed in the U.S.
Most commonFor drugs made for export that aren’t marketed in the U.S. Some regulators accept it less readily.
Check acceptanceEach drug, strength and dosage form usually needs its own certificate.
Per productThose use the FDA Certificate to Foreign Government (CFG).
See CFGChoose the country where the drug will be registered to start your order.
Embassy fees for pharmaceutical certificates vary by country. We confirm the amount with your order.
Common mistakes: notarizing the COPP, sending it to a state office, combining several products where the regulator wants one COPP per product, or a manufacturing site that differs from the dossier. Plan around the regulator’s submission deadline.
The FDA certificate for devices, food and cosmetics.
Federal route| Saudi Arabia, Morocco, Bahrain, Algeria | U.S. Department of State apostille |
| Notary or Secretary of State | Not needed |
| Embassy step | None |
| U.S. Department of State | Authentication |
| Embassy fee | By country |
| Time | Call us; plan for deadlines |
The timeline begins when the original COPPs reach our office. Checkout shows our service fee and courier cost. There is no notary or state fee.
Arab Chamber of Commerce
1615 Bay Head Rd., Annapolis, MD 21409
(410) 349-1212
1330 New Hampshire Ave. NW, B1, Washington, DC
(202) 347-5800
Monday to Friday, 8:00 am to 6:00 pm ET
No. It is an FDA document, so it goes straight to the U.S. Department of State for an apostille or authentication.
A COPP is for human drugs and follows the WHO format. A CFG is the FDA’s export certificate for food, cosmetics and medical devices.
Drug regulators in Saudi Arabia, Morocco, Bahrain and Algeria (Algeria since July 2026) accept a COPP with the State Department apostille. In Egypt, the UAE, Jordan, Kuwait, Qatar, Oman and the other Arab countries, the COPP also needs embassy legalization.
Usually yes. Each product, strength and dosage form normally has its own certificate, and each one is legalized separately.
Some Arab regulators accept it, and others want proof of U.S. marketing. Check with your regulatory agent before applying.
Tell us the products and the regulator. We’ll plan the COPP legalization around your deadline.
If you are using FedEx or UPS, please include a self-addressed air waybill for the return of your document.
Alternatively, you may use a USPS Priority Mail envelope with prepaid postage and a tracking number.
If you do not have a FedEx or UPS account, you can purchase an air waybill through this site in the next step.